Article thumbnail

Isolation, Characterization, and Stability of Discretely-Sized Nanolipoprotein Particles Assembled with Apolipophorin-III

By Nicholas O. Fischer, Craig D. Blanchette, Brent W. Segelke, Michele Corzett, Brett A. Chromy, Edward A. Kuhn, Graham Bench and Paul D. Hoeprich
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2906516
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1991). 3-dimensional structure of the LDL receptor-binding domain of human apolipoprotein-E.
  2. (2000). A
  3. (1994). A comparison of DMPC-based and DLPEbased lipid bilayers.
  4. (2007). A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein.
  5. (2007). All-trans-retinoic acid nanodisks.
  6. (2008). Amphotericin B induces interdigitation of apolipoprotein stabilized nanodisk bilayers.
  7. (2006). Apolipophorin III: Role model apolipoprotein.
  8. (2009). Apolipoprotein AI tertiary structures determine stability and phospholipidbinding activity of discoidal high-density lipoprotein particles of different sizes.
  9. (2007). Apolipoprotein E center dot dipalmitoylphosphatidylcholine particles are ellipsoidal in solution.
  10. (2003). Applications of magnetic nanoparticles in biomedicine.
  11. (2007). Applications of phospholipid bilayer nanodiscs in the study of membranes and membrane proteins.
  12. (1995). Bacterial expression and site-directed mutagenesis of a functional recombinant apolipoprotein.
  13. (1994). Binding of insect apolipophorin-III to dimyristoylphosphatidylcholine vesicles - evidence for a conformational change.
  14. (2000). cDNA and deduced amino acid sequences of apolipophorin-IIIs from Bombyx mori and Bombyx mandarina.
  15. (2008). Cell-free co-expression of functional membrane proteins and apolipoprotein, forming soluble nanolipoprotein particles.
  16. (2009). Characterization and purification of polydisperse reconstituted lipoproteins and nanolipoprotein particles.
  17. (2008). Cholesterol is a determinant of the structures of discoidal high density lipoproteins formed by the solubilization of phospholipid membranes by apolipoprotein A-I.
  18. (2007). Conformational adaptation of apolipoprotein A-I to discretely sized phospholipid complexes.
  19. (2010). Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitis.
  20. (1995). Cycling of apolipoprotein-A-I between lipid-associated and lipid-free pools.
  21. (1989). Defined apolipoprotein A-I conformations in reconstituted high-density lipoprotein disks.
  22. (2007). Different apolipoproteins impact nanolipoprotein particle formation.
  23. (2005). Following the formation of supported lipid bilayers on mica: A study combining AFM, QCM-D, and ellipsometry.
  24. (2009). Hydrogen production by a hyperthermophilic membrane-bound hydrogenase in water-soluble nanolipoprotein particles.
  25. (2009). Immobilization of His-tagged proteins on nickel-chelating nanolipoprotein particles.
  26. (2008). Insertion of membrane proteins into discoidal membranes using a cell-free protein expression approach.
  27. (2003). Lipid-binding studies of human apolipoprotein A-I and its terminally truncated mutants.
  28. (2008). Lipid-protein nanoscale bilayers: A versatile medium for NMR investigations of membrane proteins and membrane-active peptides.
  29. (2007). Liposomes in biology and medicine. Bio-Applications of Nanoparticles.
  30. (2004). Membrane proteins, lipids and detergents: not just a soap opera.
  31. (2003). Molecular dynamics investigation of an oriented cyclic peptide nanotube in DMPC bilayers.
  32. (2004). MR and fluorescent imaging of low-density lipoprotein receptors.
  33. (2009). Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.
  34. (2009). Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy.
  35. (2010). Nanodisc-incorporated hemagglutinin provides protective immunity against influenza virus infection.
  36. (2008). Nanodisks derived from amphotericin B lipid complex.
  37. (2008). Nanotechnology in vaccine delivery.
  38. (2008). New aspects of nanopharmaceutical delivery systems.
  39. (2006). Novel changes in discoidal high density lipoprotein morphology: A molecular dynamics study.
  40. (2006). Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging.
  41. (2008). Quantifying size distributions of nanolipoprotein particles with single-particle analysis and molecular dynamic simulations.
  42. (2001). Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting.
  43. (2006). Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B.
  44. (2006). Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E.
  45. (2008). Remodeling of apolipoprotein Econtaining spherical reconstituted high density lipoproteins by phospholipid transfer protein.
  46. (2003). Role of helices and loops in the ability of apolipophorin-III to interact with native lipoproteins and form discoidal lipoprotein complexes.
  47. (2002). Size is a major determinant of dissociation and denaturation behaviour of reconstituted high-density lipoproteins.
  48. (2009). Smaller discoidal highdensity lipoprotein particles form saddle surfaces, but not planar bilayers.
  49. (2000). Spectroscopic characterization of the conformational adaptability of Bombyx mori apolipophorin III.
  50. (2009). Static and dynamic properties of phospholipid bilayer nanodiscs.
  51. (2010). Structures of discoidal high density lipoproteins: a combined computational-experimental approach.
  52. (2007). Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme.
  53. (2008). The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses.
  54. (2009). Thermal stability of apolipoprotein A-I in high-density lipoproteins by molecular dynamics.
  55. (2005). Thermotropic phase transition in soluble nanoscale lipid bilayers.
  56. (1991). Transformations of reconstituted highdensity-lipoprotein subclasses as a function of temperature or LDL concentration. Biochim Biophys Acta 1085: 71–76. NLPs Assembled with apoLp-III PLoS